Structure | Compound Name | Standard Type | Standard Values (in nM) |
|---|---|---|---|
| 4-[2-(Butylamino)-5-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexan-1-ol | IC50 | 5.83 [1], 17.0 [2], 301.0 [3] | |
| Crizotinib | IC50 | 100.0 [1], 10000.0 [2] | |
| Bemcentinib | IC50 | 17.0 [1], 700.0 [2] | |
| 1-[(trans-4-Aminocyclohexyl)methyl]-N-Butyl-3-(4-Fluorophenyl)-1h-Pyrazolo[3,4-D]pyrimidin-6-Amine | IC50 | 48.0 [1] | |
| 4-[5-[4-[(4-Methyl-1,4-diazepan-1-yl)methyl]phenyl]-2-[[(2S)-pentan-2-yl]amino]pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexan-1-ol | IC50 | 3.1 [1], 9.1 [2] | |
MLA | "Quest Database™ Tyrosine-protein kinase receptor TYRO3 Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 22 Dec. 2025, https://www.aatbio.com/data-sets/tyrosine-protein-kinase-receptor-tyro3-inhibitors-ic50-ki. | |
APA | AAT Bioquest, Inc. (2025, December 22). Quest Database™ Tyrosine-protein kinase receptor TYRO3 Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/tyrosine-protein-kinase-receptor-tyro3-inhibitors-ic50-ki. | |
| BibTeX | EndNote | RefMan |